Showing results (491-500 of 512) with videos related to

Sort By:
Pageof 52
BMC Cancer|March 25, 2021
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitorsLuisa Maria Griewing, Claudia Schweizer, Philipp Schubert, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2025
Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan TrialAndreas Rimner, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.
Frontiers in Immunology|September 19, 2022
Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four multicenter clinical trialsJian-Guo Zhou, Ada Hang-Heng Wong, Haitao Wang, et al.
Cancers|July 24, 2021
A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck CancerMarkus Hecht, Dennis Hahn, Philipp Wolber, et al.
Cancers|October 14, 2022
Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck CancerMichael Beck, Sabine Semrau, Marlen Haderlein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2025
Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trialCas Stefaan Dejonckheere, Younèss Nour, Jörg Sahlmann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2025
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patientsGeorg C Lodde, Ulrike Leiter, Anja Gesierich, et al.
BMC Cancer|September 30, 2020
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancerMarkus Hecht, Dennis Hahn, Philipp Wolber, et al.
Frontiers in Oncology|March 6, 2023
Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracyThomas Weissmann, Yixing Huang, Stefan Fischer, et al.
Frontiers in Oncology|September 30, 2024
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral bloodAnna-Jasmina Donaubauer, Benjamin Frey, Manuel Weber, et al.
Pageof 52